A cell-free antibody engineering platform rapidly generates SARS-CoV-2 neutralizing antibodies

Antibody engineering technologies face increasing demands for speed, reliability and scale. We developed CeVICA, a cell-free antibody engineering platform that integrates a novel generation method and design for camelid heavy-chain antibody VHH domain-based synthetic libraries, optimized in vitro se...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xun, Gentili, Matteo, Hacohen, Nir, Regev, Aviv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605568/
https://www.ncbi.nlm.nih.gov/pubmed/33140055
http://dx.doi.org/10.1101/2020.10.29.361287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605568/
https://www.ncbi.nlm.nih.gov/pubmed/33140055
http://dx.doi.org/10.1101/2020.10.29.361287

Ejemplares similares